Karani Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.05M | Sell |
11,555
-3,690
| -24% | -$653K | 2.95% | 19 |
|
|
2023
Q2 | $2.9M | Sell |
15,245
-471
| -3% | -$89.5K | 2.92% | 20 |
|
|
2023
Q1 | $3.15M | Buy |
15,716
+88
| +0.6% | +$17.6K | 3.33% | 16 |
|
|
2022
Q4 | $3.71M | Sell |
15,628
-4,538
| -23% | -$1.08M | 4.33% | 8 |
|
|
2022
Q3 | $4.04M | Sell |
20,166
-9,819
| -33% | -$1.97M | 4.09% | 12 |
|
|
2022
Q2 | $4.37M | Sell |
29,985
-6,975
| -19% | -$1.02M | 4.04% | 12 |
|
|
2022
Q1 | $6.04M | Buy |
36,960
+2,285
| +7% | +$373K | 3.26% | 15 |
|
|
2021
Q4 | $5.88M | Buy |
34,675
+2,186
| +7% | +$371K | 2.91% | 17 |
|
|
2021
Q3 | $6.13M | Buy |
+32,489
| New | +$6.13M | 2.98% | 16 |
|
|
2021
Q2 | – | Sell |
-31,587
| Closed | -$4.46M | – | 42 |
|
|
2021
Q1 | $4.46M | Buy |
31,587
+12
| +0% | +$1.69K | 2.63% | 20 |
|
|
2020
Q4 | $4.1M | Buy |
31,575
+4,885
| +18% | +$635K | 2.43% | 18 |
|
|
2020
Q3 | $3.89M | Hold |
26,690
| – | – | 2.61% | 19 |
|
|
2020
Q2 | $3.95M | Buy |
+26,690
| New | +$3.95M | 3.06% | 15 |
|